- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The pharmaceutical company announced that it will increase its patient assistance program in hopes of quelling a growing backlash over its drug pricing.
Despite Teva Pharmaceuticals (TEVA) losing two patents for its Copaxone drug, Leerink said generics won't challenge the company until 2018.
The pharma company has been increasing the price of the epinephrine injector since 2007, so why are people finally taking notice?
Shares of the world's second largest generic pharma company fell nearly 5% after U.S. politicians target company for price gouging.